Sulforaphane: Revision history

From Glioblastoma Treatments
Jump to navigationJump to search

Diff selection: Mark the radio buttons of the revisions to compare and hit enter or the button at the bottom.
Legend: (cur) = difference with latest revision, (prev) = difference with preceding revision, m = minor edit.

12 November 2024

28 April 2024

  • curprev 09:4909:49, 28 April 2024‎ Lazy talk contribs‎ 2,919 bytes +27‎ No edit summary undo
  • curprev 09:4709:47, 28 April 2024‎ Lazy talk contribs‎ 2,892 bytes +2,892‎ Created page with "{{TreatmentInfo |drug_name=Sulforaphane |FDA_approval=No (Used as a dietary supplement; not FDA-approved for cancer treatment) |used_for=Investigational use in cancer treatment, particularly in preclinical studies focusing on glioblastoma |clinical_trial_phase=Preclinical studies |clinical_trial_explanation=Sulforaphane is being studied in preclinical models for its potential as an anti-cancer agent against glioblastoma. Research focuses on its ability to inhibit histone..."
Retrieved from "http://glioblastomatreatments.wiki:80/index.php?title=Sulforaphane"